Results 251 to 260 of about 5,217,536 (379)

Carbon markets: a new form of colonialism for Indigenous Peoples?

open access: yesLancet Planet Health
Redvers N   +7 more
europepmc   +1 more source

Nuestra Comunidad: The Role of Latin American Networks in Supporting Ecologists Throughout Their Careers

open access: yes
The Bulletin of the Ecological Society of America, EarlyView.
Shersingh Joseph Tumber‐Dávila   +5 more
wiley   +1 more source

Transformation Teams Leading the Hispanic‐Serving Institutions Movement at HSI Community Colleges

open access: yesNew Directions for Community Colleges, EarlyView.
ABSTRACT The Department of Education defunded discretionary grant programs for enrollment‐based minority‐serving institutions (MSIs) on September 10, 2025, yet Hispanic‐serving institutions (HSIs) still exist and must continue to adapt to their growing population of Latine/x students.
Gina Ann Garcia   +2 more
wiley   +1 more source

Indigenous Peoples' responses to evacuation for birth in Ontario: conceptualizing risk through an Indigenous midwifery-led approach. [PDF]

open access: yesInt J Equity Health
Campbell E   +10 more
europepmc   +1 more source

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder is a highly prevalent psychological disorder worldwide and its main treatment is the use of Selective Serotonin Reuptake Inhibitors. However, few studies have demonstrated the relationship between the presence of genetic variants in pharmacogenes and the efficacy of these drugs, especially in populations with a unique genetic ...
Kaio Evandro Cardoso Aguiar   +9 more
wiley   +1 more source

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy